GI and Cards remained highly competitive, as usual.
Pulm/Crit has rocketed past Heme/Onc to #3, clearly with the possibility of surpassing GI.
Heme/Onc a solid match.
Nephro is falling as fast as Pulm/Crit is rising. How will training programs survive? (hint: some won't)
Rheum/Allergy/Endo remain steadily popular and moderately competitive. Allergy maybe slightly more popular than the other two.
Geriatrics and ID still looking for someone, anyone, to love them.
Pulm/Crit has rocketed past Heme/Onc to #3, clearly with the possibility of surpassing GI.
Heme/Onc a solid match.
Nephro is falling as fast as Pulm/Crit is rising. How will training programs survive? (hint: some won't)
Rheum/Allergy/Endo remain steadily popular and moderately competitive. Allergy maybe slightly more popular than the other two.
Geriatrics and ID still looking for someone, anyone, to love them.